Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.49 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.49 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL774829 | 0.83 | TXNRD1 (0.54) | TXNRD1TXNRD3TXNRD2MAPTGAA | |
| SCHEMBL6054284 | 0.81 | TXNRD1 (0.55) | TXNRD1TXNRD3TXNRD2MAPTGAA | |
| SCHEMBL3326237 | 0.80 | SRC (0.48) | TXNRD1TXNRD3TXNRD2MAPTTDP1 | |
| SCHEMBL6046956 | 0.79 | TXNRD1 (0.49) | TXNRD1TXNRD3TXNRD2MAPTGAA | |
| SCHEMBL6038159 | 0.77 | TXNRD1 (0.56) | TXNRD1TXNRD3TXNRD2MAPTAOC3 | |
| SCHEMBL16724095 | 0.74 | TXNRD1 (0.52) | TXNRD1TXNRD3TXNRD2MAPTGAA | |
| SCHEMBL16722824 | 0.73 | TXNRD1 (0.51) | TXNRD1TXNRD3TXNRD2MAPTGAA | |
| SCHEMBL15049954 | 0.73 | TXNRD1 (0.48) | TXNRD1TXNRD3TXNRD2MAPTSRC | |
| SCHEMBL3489697 | 0.72 | TXNRD1 (0.50) | TXNRD1TXNRD3TXNRD2MAPTGAA | |
| SCHEMBL3328445 | 0.70 | TXNRD1 (0.66) | TXNRD1TXNRD3TXNRD2MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-28 | — | — | US | claimed |
| EP-2045004-A1 | Method of manufacturing polymer array by coating photosensitizer | Samsung Electronics Co., Ltd. (KR) | 2009-04-08 | — | — | EP | claimed |
| US-20230083189-A1 | MICROARRAYS | POLYMER FORGE, INC. | 2023-03-16 | — | — | US | disclosed |
| US-11001602-B2 | Diarylsulfide backbone containing photolabile protecting groups | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2021-05-11 | — | — | US | disclosed |
| US-20190112328-A1 | DIARYLSULFIDE BACKBONE CONTAINING PHOTOLABILE PROTECTING GROUPS | NIMBLEGEN SYSTEMS GMBH (DE) | 2019-04-18 | — | — | US | disclosed |
| EP-2914607-B1 | PHOTOCLEAVABLE LINKER MOLECULES WITH DIARYLSULPHID BACKBONE FOR TRANSIENT BIOCONJUGATE SYNTHESIS | VENTANA MED SYST INC (US) | 2017-11-29 | — | — | EP | disclosed |
| US-9790243-B2 | Photocleavable linker molecules with diarylsulphide backbone for transient bioconjugate synthesis | VENTANA MEDICAL SYSTEMS, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| EP-2821792-B1 | Whole proteome tiling microarrays | HOFFMANN LA ROCHE (CH) | 2017-09-13 | — | — | EP | disclosed |
| EP-2686351-B1 | METHODS FOR SYNTHESIS OF AN OLIGOPEPTIDE MICROARRAY | ROCHE DIAGNOSTICS GMBH (DE) | 2017-06-28 | — | — | EP | disclosed |
| US-9346892-B2 | Methods for synthesis of an oligopeptide microarray | ROCHE NIMBLE GEN, INC. (US) | 2016-05-24 | — | — | US | disclosed |
| US-20160060286-A1 | DIARYLSULFIDE BACKBONE CONTAINING PHOTOLABILE PROTECTING GROUPS | NIMBLEGEN SYSTEMS GMBH (DE) | 2016-03-03 | — | — | US | disclosed |
| US-20050170281-A1 | Method of cleaving labile functional groups from chemical compounds | NIMBLEGEN SYSTEMS, INC. | 2005-08-04 | — | — | US | disclosed |
| EP-1519941-A2 | A METHOD OF CLEAVING LABILE FUNCTIONAL GROUPS FROM CHEMICAL COMPOUNDS | Chemogenix GmbH (DE) | 2005-04-06 | — | — | EP | disclosed |
| EP-1480927-A2 | A METHOD FOR CLEAVAGE OF LABILE FUNCTIONAL GROUPS FROM CHEMICAL COMPOUNDS | Universität Konstanz (DE) | 2004-12-01 | — | — | EP | disclosed |
| WO-2004089529-A1 | METHOD FOR THE INTRAMOLECULAR ENERGY TRANSFER FOR THE CLEAVAGE OF LABILE FUNCTIONAL GROUP FROM BIOMOLECULES AND THE PROTECTED BIOMOLECULES | Universität Konstanz (DE) | 2004-10-21 | — | — | WO | disclosed |
| US-20040203036-A1 | Multimer polynucleotide synthesis | CHEMOGENIX GMBH (DE) | 2004-10-14 | — | — | US | disclosed |
| EP-1409505-A1 | MULTIMER POLYNUCLEOTIDE SYNTHESIS | Chemogenix GmbH (DE) | 2004-04-21 | — | — | EP | disclosed |
| WO-2004001033-A2 | A METHOD OF CLEAVING LABILE FUNCTIONAL GROUPS FROM CHEMICAL COMPOUNDS | CHEMOGENIX GMBH (DE) | 2003-12-31 | — | — | WO | disclosed |
| WO-2003074542-A2 | A METHOD FOR CLEAVAGE OF LABILE FUNCTIONAL GROUPS FROM CHEMICAL COMPOUNDS | Universität Konstanz (DE) | 2003-09-12 | — | — | WO | disclosed |
| WO-2003006476-A1 | MULTIMER POLYNUCLEOTIDE SYNTHESIS | CHEMOGENIX GMBH (DE) | 2003-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | POLL, POLRMT, POLN | TXNRD1 2630/4885TXNRD3 1636/4885TXNRD2 2491/4885 |
| US-20040203036-A1 | Multimer polynucleotide synthesis | NT5C3B, PCNA, POLL | TXNRD1 4314/4885TXNRD3 3275/4885TXNRD2 3605/4885 |
| US-11001602-B2 | Diarylsulfide backbone containing photolabile protecting groups | CRY2, PRXL2A, MGMT | TXNRD1 2015/4885TXNRD3 505/4885TXNRD2 1062/4885 |
| US-20160060286-A1 | DIARYLSULFIDE BACKBONE CONTAINING PHOTOLABILE PROTECTING GROUPS | CRY2, PRXL2A, MGMT | TXNRD1 2015/4885TXNRD3 505/4885TXNRD2 1062/4885 |
| US-20190112328-A1 | DIARYLSULFIDE BACKBONE CONTAINING PHOTOLABILE PROTECTING GROUPS | CRY2, PRXL2A, MGMT | TXNRD1 2015/4885TXNRD3 505/4885TXNRD2 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.